TABLE 3.

Concepts, themes, and findings about a value proposition of pharmacogenetic testing in mental health care from individual interviews with N = 29 prescribers.

Concepts 32	Themes	Findings
Quality	The Art of Prescribing Prescribers must use their own skill to determine the best course of action for each individual case.	No clear advantage of pharmacogenetic testing over the standard of care for adopters and non‐adopters though improves confidence in prescribing; certain non‐adopters expressed that pharmacogenetic testing would interfere with the relational aspect of prescribing
Population Health	Meeting Patients' Needs Pharmacogenetic testing can help meet population‐level needs for mental health care.	Primary care prescribers discussed the advantage of reducing inequities in access to mental health care by using pharmacogenetic testing, while psychiatrists did not perceive the advantage
Cost	Considering patients' costs Adopting and non‐adopting providers differentially considered test costs a barrier for testing patients	Although prescribers overall viewed pharmacogenetics as potentially saving costs from trial and error, certain adopters let patients decide willingness to pay, while non‐adopters did not view the information as worth any out‐of‐pocket cost